Benzodiazepines
are neuromodulatory drugs that potentiate GABA-mediated conductance increases. We report the findings of an investigation into the effect of a full benzodiazepine-positive modulator (agonist), chlordiarepoxide (CDPX), on desensitization of the GABA response in chick spinal cord neurons maintained in primary monolayer cell culture. GABA application initially increases cell conductance, which then desensitizes.
CDPX increases the apparent rate constant and extent of desensitization for the GABA response. The observed values for rate constant and extent of desensitization in the presence of CDPX are significantly greater than the values predicted for an equivalent peak response to GABA alone. Flunitrazepam, another full positive modulator, also stimulates the rate constant for GABA-induced desensitization. Furthermore, a weak partial benzodiazepine-positive modulator, Rol5-1788 (an imidarodiazepine) (1) exhibits little or no potentiation of GABA-induced desensitization, and (2) antagonizes the ability of CDPX to stimulate GABA desensitization.
The results demonstrate a novel form of neuromodulator action: the stimulation of receptor desensitization that cannot be explained by channel blockade. Thus, benzodiazepine modulators have the capacity to increase GABA receptor desensitization while increasing the peak response to GABA.
The cellular response of many receptor systems fades, or desensitizes, upon continued exposure to receptor agonists. Whereas the phenomenon of desensitization to agents such as neurotransmitters, hormones, chemotactic agents, and drugs is well known (Levitzki, 1986) , its biological function remains unclear, particularly for neurotransmitter receptors that are coupled to ion channels. At many chemical synapses, synaptic potentials last several milliseconds, while desensitization takes seconds to minutes. It is not yet known whether desensitization may serve to regulate neural responses that involve persistent synaptic activity.
GABA, a major inhibitory neurotransmitter in the vertebrate CNS, exerts its action by selectively increasing membrane chloride permeability. The GABA receptor-chloride ionophore complex has emerged as a locus of action for a wide variety of compounds, reflecting the unique capacity of this system to be diversely modulated (Olsen, 1982) . The past decade has been a period of intense investigation into the mechanism by which benzodiazepine drugs interact with the GABA receptor complex (Costa et al., 1975; Haefely, 1984) . Electrophysiological studies have focused primarily on the observation that benzodiazepines potentiate GABA-mediated conductance increases (Choi et al., 1977; Study and Barker, 198 1) through the benzodiazepinesensitive modulator site (Farb et al., 1984) . However, little is known of benzodiazepine interactions with the process of GABA receptor desensitization. Here we report the results of an investigation into the effect of a benzodiazepine, chlordiazepoxide (CDPX), on desensitization ofthe GABA response in embryonic chick spinal cord cell cultures. We find that CDPX stimulates the rate and extent of GABA receptor desensitization over and above the level predicted for an equivalent GABA response in the absence of CDPX. Furthermore, the imidazodiazepine Rol5-1788, a weak partial agonist of the benzodiazepine receptor, antagonizes the CDPX-stimulated desensitization. A preliminary report of this work has been presented (Mierlak and Farb, 1985) .
Materials and Methods
Benzodiazepines were generously provided by Dr. P. Sorter of F. Hoffman-La Roche (Nutley, NJ). All other chemicals were obtained from commercial sources.
Neuronal cultures were prepared from spinal cords of 6-7-d-old chick embryos as previously described (Farb et al., 1979) and maintained for 2-5 weeks. Electrophysiological experiments were performed on the stage of an inverted microscope equipped with phase-contrast optics.
Cultures were kept at 35-37°C and perfused (1 ml/min, bath volume 2-3 ml) with recording medium at pH 7.4 (Earle's balanced salts solution supplemented with 2.2 mM CaCl,, 16 mM glucose, 0.25% horse serum, and either 9.2 mM MgSO, or 50 nM tetrodotoxin to suppress spontaneous activity). Recordings were obtained with 3 M KCl, 4 M potassium acetate (KAc), or 0.5 M KAc electrodes (R = 30-80 MB) under singleelectrode current-clamp conditions.
Membrane conductance (g,) was determined from Ohm's Law after measuring the voltage response to hyperpolarizing constant-current pulses (100 msec, 1 Hz, 0.2-l .2 nA) injected across the membrane by means of a bridge circuit. Cells that did not exhibit a resting potential of at least -50 mV, a linear current-voltage relationship (Fig. l) , and unambiguous bridge balance were excluded from study. Occasionally, some neurons exhibited GABA responses that were not potentiated by CDPX; these neurons were not studied. Conductance observed in the presence of GABA (gobs) was corrected by subtracting g,,, to yield conductance due to GABA (go,,) . Voltage responses to current injection were measured from the chart recorder traces or by computer.
Water-soluble drugs were dissolved in recording medium without horse serum and applied to single neurons by pressure-ejection from 7-barrel blunt-tip pipettes (3-5 rm/barrel). Water-insoluble drugs were first dissolved in dimethyl sulfoxide and then diluted in recording medium without horse serum to a final concentration of 0.2% dimethyl sulfoxide, which did not in itself affect membrane potential or conductance. Statistical significance was assessed using a 2-tailed Student's t test.
Two parameters were chosen for quantitation of GABA receptor desensitization: the extent of desensitization (%D) and the apparent rate constant for onset of desensitization (k,,,) . The conductance increase in response to pressure-ejection of GABA reaches a peak (peak go,,,) and then desensitizes to a steady-state level (gss). Extent of desensitization (%D) was defined as [(peak go,,,, -g&/peak go,,,] x 100%. To evaluate k,,,, the value of g,, was subtracted from go,, values comprising the first 80% of decay; (gCABA -gss) was then plotted semilogarithmically against time. The best straight line was used to determine k,,, as follows: k,,, = 0.693&, where t, is the time required for any (goABA -gss) value to decay by 50%. In some experiments, k,,, was determined by a nonlinear-regression curve-fitting program. Occasionally, nonlinear-regression analysis favored a double-exponential decay. In such cases, the rate constant for the initial, fast phase was used for analysis.
The value of %D depends on measurement of the peak response, as well as on the steady-state level of desensitization. For the results presented, the largest go,,, value measured after the start of GABA application was taken as the peak response. However, the time required to reach the peak response is variable (generally between 1 and 5 set). It is possible that the peak response measured for cells that display a longer time to reach peak represents an underestimate of the "true" peak response, since desensitization is presumably taking place during the rising phase of the response. In these cases %D may also be under- estimated. Evaluation of the true peak response may be standardized by back-extrapolating desensitization-onset plots to time zero (onset of GABA application) and using this extrapolated value to determine %D. However, this would lead to an overestimate of peak response and %D, since it clearly takes some period of time for the drug solution to be expelled from the pipette tip, to displace the surrounding bathing medium, to diffuse to, and to interact with, the receptors. It seems certain that the "true" peak response and %D lie within the range defined by the 2 methods of analysis. Both methods of calculation of peak response and %D were employed and the results compared. Although, as expected, the values for peak response and %D increased when calculated by back-extrapolation, importantly, the conclusions drawn from the use of these values were independent of the method of analysis.
The use of KC1 recording electrodes results in an increased intracellular chloride ion concentration, which shifts the reversal potential for chloride to about -20 mV. Application of GABA, which increases chloride conductance, then produces a depolarization. To ensure that the results obtained with KC1 electrodes were not dependent on depolarization, we recorded from neurons with KAc electrodes. These electrodes do not alter the intracellular chloride ion concentration. Under these conditions, GABA induces a smaller depolarization, which could often be minimized by depolarizing the cell with a small, constant, positive current before applying GABA.
Results
Desensitization of the response to GABA Every spinal cord neuron successfully impaled is responsive to GABA, although the degree of responsiveness is variable from cell to cell. For most cells, the conductance increase induced by 10 PM GABA (EC,, = 17 PM) desensitizes upon prolonged application (Fig. 2) . Recovery from desensitization is complete within 3-4 min for 10 PM GABA. In a sample of 19 neurons impaled with 3 M KC1 electrodes and exposed to 10 PM GABA, %D is 72 + 2% and k,,, is 0.069 f 0.006 set-I (means f SEM; Table 1 ). Depolarizations of 20-30 mV are generally seen with 10 PM GABA appliCatiOnS.
To control for the depolarization seen with KC1 recording electrodes (see Materials and Methods), we applied 10 PM GABA to neurons impaled with KAc electrodes. Under these conditions, depolarization rarely exceeds 10 mV and, in many cases, application of GABA causes no change in potential or a hyperpolarization. For 58 neurons impaled with KAc electrodes and exposed to 10 PM GABA, %D is 63 f 2% and k,,, is 0.074 & 0.005 see-I (means f SEM; Table 1 ).
Dependence of %D and k,,, on GABA concentration To investigate the relationship between GABA concentration and both %D and k,,,, several different concentrations of GABA were applied to individual neurons. %D increases with increasing GABA concentration (18 neurons) using KC1 or KAc recording electrodes. For KC1 electrodes, plots of %D against peak response to GABA (1 O-22 MM) are linear. Using KAc electrodes, such plots are either linear or curvilinear over a wide range of GABA concentrations (lo-300 PM). kZpp also increases with increasing GABA concentration (19 neurons). Plots of k,,, against peak response are linear, using both KC1 and KAc electrodes.
Effect of CDPX on desensitization CDPX, a water-soluble benzodiazepine, was tested for its effect on desensitization of the GABA response. In the presence of near-saturating CDPX (200-430 KM; EC,, = 17 PM), the peak response to 10 WM GABA (peak gGGABA') is potentiated and both %D and k,,, increase (Fig. 3) . In 11 neurons impaled with KC1 electrodes, the presence of 300 WM CDPX increased %D by 29% out of a theoretical maximum of 37% (Table 2 ). The value of k,,, in the presence of CDPX (k,,,') is 3.7-fold greater than that of k,,, for GABA alone (Table 2) . Twenty-four neurons impaled with KAc electrodes demonstrated a similar significant increase in %D and k,,, in the presence of CDPX .
The ability to accelerate desensitization is not limited to CDPX. Flunitrazepam (0.5-2 PM; EC,, = 180 nM), another full benzodiazepine agonist, was found to accelerate GABA (10 MM)-induced desensitization in 6 out of 6 neurons impaled with KAc electrodes. k,,, increased 2.9 + 0.8-fold in the presence of flunitrazepam, as compared with an average increase of 3.1 + 0.6- Given the potentiation of peak g,,,, by CDPX, it is important to determine whether this increase in peak response can account for the enhancement of %D and k,,, seen in the presence of CDPX. A series of GABA concentrations was applied to individual neurons impaled with KC1 electrodes, and then 10 PM GABA plus 300 PM CDPX was applied. Since the plots of both %D and k,,, against peak g,,,, were linear over the GABA range used, it was possible to compare the observed values for the apparent rate constant (k,,,') and %D in the presence of CDPX with the corresponding values for an equivalent peak GABA response in the absence of CDPX. In 5 of 6 neurons, the observed values for both kapp' and %D in the presence of CDPX were greater than those predicted for equivalent peak g,,,, values elicited by GABA alone (Figs. 4, 5) . A 19% increase in %D was predicted from CDPX potentiation of peak g,,,,; however, a 36% increase was observed. For k,,,, a 1.8-fold increase was predicted, but a 3.6-fold increase was observed with CDPX.
Results from 9 neurons impaled with KAc electrodes corroborated the KC1 findings. CDPX enhanced %D over predicted levels in 8 of 9 neurons, while k,,, was enhanced in 7 of 9 neurons. In these experiments, depolarization upon GABA ap- plication was usually under 5 mV (maximum, 8 mV). The degree of enhancement over predicted levels was similar to that seen for KC1 recordings.
Ro15-1788 antagonizes CDPX-stimulated desensitization
To verify that the enhancement of %D and k,,, seen in the presence of CDPX was mediated through the benzodiazepine receptor, experiments were performed with Ro 15 1788, an imidazodiazepine that behaves as a weak partial agonist in its ability to potentiate go,,, (Chan and Farb, 1985) . Ro15-1788, when applied at saturating concentrations (l-2 KM) with 10 PM GABA, had little effect on %D and k,,, compared to control values for 10 PM GABA alone [in the presence of Ro15-1788, k,,, increased 1.2-fold (p > 0.1); %D increased 11% out of a maximum 39% @ < 0.025); n = 5 neurons, KC1 electrodes]. The interaction of Ro 15-1788 with CDPX was tested in 2 cells as follows: A 30 set prepulse of 2 FM Ro 15-1788 was followed by a 10 set pulse of 2 PM Rol5-1788 plus 300 PM CDPX, after which 10 PM GABA, 2 PM Ro 15-1788, and 300 FM CDPX were The hatched bar represents the predicted value of k,,, for a GABA pulse alone with a peak response equivalent to 10 WM GABA + 300 PM CDPX. The predicted increase in k,,, is only 1.8-fold. B, %D for 10 PM GABA (open bar) increases by 36% when 300 PM CDPX is present (so/id bar). The hatched bar represents the predicted value of%D for a GABA pulse alone with a peak response equivalent to GABA + CDPX. The predicted increase in %D is only 19%. The stippled bar is the maximum %D possible, corresponding to a 45% increase over 10 PM GABA alone. Data are means + SEM; 5 neurons; KC1 electrodes. *Significantly different: A, p < 0.005; B, p < 0.05.
applied. In both cells, the enhancement of%D and k,,, by CDPX (compared to control 10 FM GABA values) was reduced by about 40 and 50%, respectively, when CDPX was applied in the presence ofRo15-1788 (Fig. 6) . The antagonism by Ro15-1788 was expected to be partial, since both Ro15-1788 and CDPX were competing for the benzodiazepine site at saturating concentrations.
The phenomenon of receptor desensitization may be viewed as a modulatory response of the cell to acute, persistent activation of a receptor system. But there is, at present, no comprehensive model that satisfactorily explains neurotransmitter receptor desensitization either mechanistically or teleologically. It is, therefore, impossible to predict for the GABA receptor whether and how modulatory agents might alter GABA desensitization.
The main conclusions of this study relate to the control of GABA receptor desensitization by benzodiazepine neuromodulators. The ability of benzodiazepines to potentiate GABA chemosensitivity has been well established in electrophysiological studies (Choi et al., 1977, 198 1; Study and Barker, 198 1) . Notably, CDPX has been shown to shift the GABA dose-response curve to the left in a parallel fashion (Choi et al., 198 l) , suggesting that potentiation in the presence of CDPX is due to an increase in the affinity of the GABA receptor for GABA. The benzodiazepines might be expected to enhance desensitization of GABA responses by virtue of this increase in GABA receptor affinity. Alternatively, GABA desensitization might not be triggered by chloride channel activity, but might, rather, result from the binding of GABA to a distinct site. In this model, the benzodiazepine neuromodulators could either increase desensitization more than is predicted from the peak response to GABA, exert no effect upon desensitization, or even inhibit desensitization.
Here we demonstrate directly that a benzodiazepine, CDPX, stimulates the rate and extent of desensitization produced in response to 10 WM GABA. Surprisingly, CDPX stimulates desensitization more than is predicted from the degree of potentiation produced. Thus, stimulation does not simply reflect The finding that Rol5-1788 antagonizes CDPX stimulation of desensitization suggests that the benzodiazepine receptor mediates this effect. Biochemical (Mohler and Richards, 198 1) and electrophysiological (Chan and Farb, 1985) studies, respectively, have shown that Rol5-1788 binds to the benzodiazepine receptor, but behaves as a weak partial agonist. Analogously, Ro 15-1788 could possess weak intrinsic activity as a modulator of desensitization. This may account for the small enhancement of %D by Ro15-1788 alone. The ability of Ro15-1788 to antagonize CDPX stimulation of desensitization indicates that (1) CDPX is not exerting its effect via a channel-block mechanism, and (2) benzodiazepine receptor occupancy alone is insufficient to produce stimulation of GABA receptor desensitization. Significantly, the results strongly suggest that stimulation of desensitization depends on the efficacy of the ligand bound to the benzodiazepine receptor.
The general agreement between results obtained from KC1 and KAc recordings indicates that the depolarization seen in KC1 recordings is not confounding or generating the findings presented. One possible exception to this is the greater %D value for 10 PM GABA seen with KC1 electrodes (Table 1 ). This may be related to depolarization if peak g,,,, is being overestimated due to a contribution from increased potassium conductance activated by depolarization.
The mechanism for the stimulation ofdesensitization remains to be elucidated. It seems likely, however, that CDPX binds to the benzodiazepine site with higher affinity when the GABA receptor is desensitized. GABA is known to enhance benzodiazepine binding to cortical membranes (Briley and Langer, 1978; Tallman et al., 1978) . These in vitro studies are performed at equilibrium, a condition under which the GABA receptor is expected to be desensitized (>20 min incubation time for Figure 6 . Ro 15-1788 antagonizes CDPX enhancement of GABA-induced desensitization. Time course for desensitization, in a single neuron, to 10 PM GABA applied alone (0) in the presence of 300 WM CDPX (O), and in the presence of both 300 PM CDPX and 2 PM Ro15-1788 (x) . %D is 53 and 87%, respectively, for GABA and GABA + CDPX, which represents a 64% increase in the presence of CDPX. %D for GABA in the presence of CDPX + 1788 is 75%, representing a 42% increase over that for GABA atone. Thus, the presence of Ro15-1788 reduces CDPX enhancement by 34% [ 1 -(42%/64%) x lOO%]. Furthermore, Ro 15-1788 reduces CDPX enhancement of k.,, by 46%. Similar values were obtained in another neuron. The data shown are from consecutive applications to a single neuron. With regard to peak response, this sequence was repeated twice on this cell and the results, together with data from another cell, demonstrate that the presence of Ro 15-1788 reduces the peak response of GABA + CDPX to within that for GABA alone.
GABA). This suggests that benzodiazepines have a higher affinity for binding when the GABA receptor is desensitized (Farb et al., 1984) . The stimulation of desensitization described here is consistent with this prediction. By stabilizing the desensitized GABA receptor, benzodiazepines would be expected to increase the extent of desensitization. If GABA receptor desensitization proceeds and recovers via isomerization events, as proposed for the acetylcholine receptor, then a stabilization of the desensitized state would be accompanied by either an increase in the rate of onset for desensitization, a decrease in the rate of recovery from desensitization, or both. The enhancement of k,,,, therefore, provides support for this model. An earlier report (Choi et al., 1981) showed that the ability of CDPX to potentiate g,,,, in chick spinal cord cultures is unaffected by a 2 hr exposure to CDPX. This indicates that the CDPX effect does not desensitize and, importantly, that CDPX does not directly desensitize the GABA response. Taken together, the results support a model consistent with the synergistic action of CDPX and GABA on desensitization of the GABA receptor.
Thus, the results demonstrate that GABA action is modulated by benzodiazepines at 2 levels: (1) stimulation of GABA receptor desensitization, and (2) potentiation of the peak response to GABA. At present, a physiological role for the stimulation of desensitization is unclear. The involvement of densitization in control of synaptic efficacy during persistent neurotransmitter action, or as a cellular control mechanism (perhaps requiring the activation of a second messenger), presents attractive possibilities and will require further investigation. We speculate that this rapid stimulation of desensitization may trigger the onset of persistent subsensitivity of the GABA receptor to enhancement by benzodiazepines during chronic exposure to diazepam (Gonsalves and Gallager, 1985) . It is interesting that modulation of desensitization does not appear to be restricted to the GABA receptor complex. At the nicotinic acetylcholine receptor, substance P is thought to enhance desensitization (Clapham and Neher, 1984) , although, in striking contrast to the action of CDPX at the GABA receptor, substance P enhancement of desensitization is associated with a decrease in the amplitude of the peak response to acetylcholine. The occurrence of stimulation of desensitization in 2 separate transmitter systems suggests that this phenomenon may represent an important mechanism of action for neuromodulation at neurotransmitter receptors in general.
